Table 3.

Results (median and range) of comparisons between the omentin marker assays and various clinical parameters.

Parameters	Marker assays
	n	Omentin (ng/mL) Median (range)	p
Age patients
Young (< 60)	18	8.19 (3.62–219.48)	0.40
Older (> 60)	15	10.48 (5.15–204.24)
Gender
Male	20	10.30 (3.62–219.48)	0.92
Female	13	9.27 (5.85–194.50)
PS
Good (0–1)	23	10.28 (3.62–219.48)	0.84
Worse (2–4)	9	9.57 (3.62–204.24)
Weight loss
Yes	26	9.93 (3.62–205.14)	0.79
No	4	74.69 (5.15–219.48)
Jaundice
Yes	9	7.49 (3.62–193.88)	0.45
No	22	10.30 (3.62–219.48)
Surgery
Yes	8	7.78 (5.26–205.14)	0.75
No	25	9.42 (3.62–219.48)
Localization
Head	21	8.59 (3.62–205.14)	0.44
Corpus-tail	10	10.60 (3.62–204.24)
pT size
Small (< 40 mm)	14	7.65 (3.62–193.88)	0.03⁎
Large (≥ 40 mm)	14	74.29 (3.62–205.14)
Metastasis
Yes	23	10.34 (3.62–219.48)	0.43
No	10	8.05 (3.62–193.88)
Liver metastasis
Yes	19	10.34 (5.26–219.48)	0.41
No	4	71.25 (3.62–188.14)
ESH
Normal	11	9.42 (3.62–219.48)	0.70
High	12	7.78 (5.37–205.14)
Hb
Low	12	10.48 (5.15–219.48)	0.08
Normal	19	7.13 (3.62–204.24)
WBC
High	9	7.78 (5.26–204.24)	0.88
Normal	22	10.30 (3.62–219.48)
PLT
Low	5	10.86 (6.63–219.48)	0.39
Normal	26	8.93 (3.62–205.14)
Albumin
Low	17	7.50 (3.62–194.50)	0.68
Normal	10	10.28 (5.15–219.48)
LDH
High	8	10.03 (5.42–204.24)	0.58
Normal	21	8.59 (3.62–219.48)
CEA
High	19	74.11 (5.42–219.48)	0.09
Normal	10	7.78 (3.62–205.14)
CA 19.9
High	22	9.95 (3.62–205.14)	0.50
Normal	7	8.59 (5.15–219.48)
Response to CTx
Yes (PR + SD)	8	7.78 (3.62–205.14)	0.71
No (PD)	7	7.41 (5.15–249.48)

^⁎p ≤ 0.05.